Page last updated: 2024-09-04

purpurin 18 and Triple Negative Breast Neoplasms

purpurin 18 has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Huang, P; Leung, W; Xu, C; Yuan, Q; Zhang, B; Zhang, X	1

Other Studies

1 other study(ies) available for purpurin 18 and Triple Negative Breast Neoplasms

Article	Year
Photodynamic treatment with purpurin 18 effectively inhibits triple negative breast cancer by inducing cell apoptosis. Lasers in medical science, 2021, Volume: 36, Issue:2 Topics: Animals; Apoptosis; Body Weight; Cell Line, Tumor; Female; Humans; Light; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Mitochondria; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Porphyrins; Spheroids, Cellular; Subcellular Fractions; Triple Negative Breast Neoplasms; Tumor Burden	2021

Article

Year

Photodynamic treatment with purpurin 18 effectively inhibits triple negative breast cancer by inducing cell apoptosis.

Lasers in medical science, 2021, Volume: 36, Issue:2

Topics: Animals; Apoptosis; Body Weight; Cell Line, Tumor; Female; Humans; Light; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Mitochondria; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Porphyrins; Spheroids, Cellular; Subcellular Fractions; Triple Negative Breast Neoplasms; Tumor Burden

2021